Table of Contents Table of Contents
Previous Page  64 / 72 Next Page
Information
Show Menu
Previous Page 64 / 72 Next Page
Page Background

Bone formation and degradation behavior of nanocrystalline hydroxyapatite with

or without collagen-type 1 in osteoporotic bone defects

an experimental

study in osteoporotic goats

Volker Alt

a,b

, Wing Hoi Cheung

c

, Simon K.H. Chow

c

, Ulrich Thormann

b

, Edmond N.M. Cheung

c

, Katrin S. Lips

b

,

Reinhard Schnettler

a,b

, Kwok-Sui Leung

c,

*

a

Department of Trauma Surgery, University Hospital of Giessen-Marburg GmbH, Campus Giessen, 35385 Giessen, Germany

b

Laboratory of Experimental Trauma Surgery Giessen, Justus-Liebig-University Giessen, 35394 Giessen, Germany

c

Department of Orthopaedics and Traumatology, The Chinese University of Hong Kong, Hong Kong, China

A B S T R A C T

The intention of the current work is to assess new bone formation and degradation behavior of nanocrystalline

hydroxyapatitewith (HA/col-1) or without collagen-type I (HA) in osteoporotic metaphyseal bone defects in goats.

After ovariectomy and special low-calcium diet for three months, 3 drill hole defects in the vertebrae of L3, L4, L5, 4

drill hole defects in the right and left iliac crest and 1 drill hole defect at the distal femur were created in three

Chinese mountain goats with a total of 24 defects. The defects were either filled with one of the biomaterials or left

empty (empty defect control group). After 42 days, the animals were euthanized and the samples were assessed

for new bone formation using high-resolution peripheral quantitative computed tomography (HR-pQCT) and

histomorphometry with 2 regions of interest. Detail histology, enzymehistochemistry and immunohistochemistry

as well as connexin-43 in situ hybridization and transmission electron microscopy were carried out for evaluation

of degradation behavior of the materials and cellular responses of the surrounding tissue in respect to the

implants. HR-pQCT showed the highest BV/TV ratio (

p

= 0.008) and smallest trabecular spacing (

p

= 0.005) for HA

compared to the other groups in the region of interest at the interface with 1 mm distance to the initially created

defect. The HA/col-1 yielded the highest connectivity density (Conn.D) (

p

= 0.034) and the highest number of

trabeculae (Tb.N) (

p

= 0.002) compared to the HA and the control group. Histomorphometric analysis for the core

region of the initially created defect revealed a statistically higher new bone formation in the HA (

p

= 0.001) and

HA/col-1 group (

p

= 0.001) compared to the empty defect group including all defect sites. This result was

confirmed for site specific analysis with significant higher new bone formation for the HA group for vertebral

defects compared to the empty defect group (

p

= 0.029). For the interface region, no statistically significant

differences were found between the three groups (

p

= 0.08). Histology revealed a good biocompatibility without

inflammatory reaction for the HA- and HA/col-1 implants with a higher fragmentation of the HA-implant

compared to the HA/col-1 biomaterial and formation of new bone in the region between the biomaterial

fragments by osteoblasts. Fragmentation was shown by transmission electron microscopy to be caused by

multinuclear osteoclast-like cells with degradation of the implant via intracellular incorporation of degraded

implant material particles. In conclusion, both nanoparticulate HA with and without collagen type-1 showed

better new bone formation compared to untreated drill hole defects in metaphyseal regions of this osteoporotic

Chinese mountain goat model with good biocompatibility.

© 2016 Elsevier Ltd. All rights reserved.

K E Y W O R D S

Hydroxyapatite

Collagen

Osteoporosis

Degradation

Biomaterial

*

Corresponding author at: Volker Alt, Department of Trauma Surgery Giessen, University

Hospital Giessen-Marburg GmbH, Campus Giessen, Rudolf-Buchheim-Strasse 7, 35385

Giessen, Germany. Tel.:

+49 (0)641 985 44

601; fax:

+49 (0)641 985 44

609.

E-mail address:

volker.alt@chiru.med.uni-giessen.de

(Volker Alt).

Injury, Int. J. Care Injured 47S2 (2016) S58

S65

Contents lists available at ScienceDirect

Injury

journal homepage: www.

elsevier.com/locate/Injury

0020-1383 / © 2016 Elsevier Ltd. All rights reserved.